Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

Neurological disorders and neuro oncology impose a growing clinical and societal burden, while therapeutic development remains slow, costly, and uncertain.

AI life science benchmark LifeSciBench, published June 17 by OpenAI with 173 PhD scientists, shows frontier models clear only ...

The global "Germany Spatial Genomics & Transcriptomics market" is a dynamic and growing industry. By understanding the key trends, upcoming technologies, and growth opportunities, Germany Spatial ...

OpenAI published a substantial update to GPT-Rosalind on June 3, 2026, deepening the domain-specialized model's performance across drug discovery, genomics, and wet-lab research — and opening the ...

Microglia, the resident immune sentinels of the central nervous system (CNS), have emerged as central regulators of immune–neural interactions and ...

Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.

HisCMCL is an innovative deep learning framework developed to improve the accuracy of spatial gene expression prediction. This framework combines features from Hematoxylin and Eosin (H&E) stained ...

PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the ...